(Q28166742)

https://api.crossref.org/works/10.1007%2FBF03256645

Complexities of the genetics of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Peak flow variability, methacholine responsiveness and atopy as markers for detecting different wheezing phenotypes in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Two subphenotypes of childhood asthma that differ in maternal and paternal influences on asthma risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Leukotrienes and lipoxins: structures, biosynthesis, and biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Chemokinetic activity of arachidonic acid lipoxygenase products on leuocyctes of different species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Leukotriene B4 action on endothelium mediates augmented neutrophil/endothelial adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Cysteinyl leukotrienes in asthma: old mediators up to new tricks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Montelukast: a review of its therapeutic potential in persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Pathology of asthma and its clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Efficacy of antileukotriene agents in asthma management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Effect of oral prednisone on airway inflammatory mediators in atopic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Dexamethasone Increases Expression of 5‐Lipoxygenase and its Activating Protein in Human Monocytes and THP‐1 Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on short-acting beta(2)-agonists alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Bronchoprotection with a leukotriene receptor antagonist in asthmatic preschool children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Comparison of montelukast versus budesonide in the treatment of exercise-induced bronchoconstriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Treatment of aspirin-intolerant asthma with antileukotrienes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Induced Sputum Eicosanoid Concentrations in Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Leukotriene receptor antagonists may prevent NSAID-induced exacerbations in patients with chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Effectiveness and tolerability of zafirlukast for the treatment of asthma in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Long-term safety and efficacy of zafirlukast in the treatment of asthma: interim results of an open-label extension trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Effects of zafirlukast upon clinical, physiologic, and inflammatory responses to natural cat allergen exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Efficacy and duration of action of the antileukotriene zafirlukast on cold air-induced bronchoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Efficacy and safety of long-term treatment of asthmatic patients with pranlukast, a cysteinyl-leukotriene-receptor antagonist: four-year followup study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Effects of pranlukast, a leukotriene receptor antagonist, on airway inflammation in mild asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Comparative role of peptide leukotrienes and histamine in the development of nasal mucosal swelling in nasal allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Comparative effects of long-acting beta2-agonists, leukotriene receptor antagonists, and a 5-lipoxygenase inhibitor on exercise-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

A pilot study examining the role of zileuton in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged > or = 6 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Severe liver injury after treatment with the leukotriene receptor antagonist zafirlukast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Acute hepatocellular injury associated with zafirlukast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Safety of antileukotriene agents in asthma management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Fulminant eosinophilic endomyocarditis in an asthmatic patient treated with pranlukast after corticosteroid withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Leukotriene modifiers and Churg-Strauss syndrome: adverse effect or response to corticosteroid withdrawal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Churg-Strauss Syndrome in Patients Receiving Montelukast as Treatment for Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Effect of asthma and its treatment on growth: four year follow up of cohort of children from general practices in Tayside, Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Fluticasone propionate versus zafirlukast: effect in patients previously receiving inhaled corticosteroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Nonadherence in asthmatic patients: is there a solution to the problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Measurement of children's asthma medication adherence by self report, mother report, canister weight, and Doser CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

How often is medication taken as prescribed? A novel assessment technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

A comparison of asthma-related expenditures for patients started on montelukast versus fluticasone propionate as monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Long-term effects of budesonide or nedocromil in children with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Apoptosis of airway epithelial cells induced by corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

NO in Exhaled Air of Asthmatic Children Is Reduced by the Leukotriene Receptor Antagonist Montelukast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645

Guidelines update: where do the new therapies fit in the management of asthma? NHLBI and WHO Global Initiative for Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256645